We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Promoting Adaptive Clinical Trial Design With New Guidances
FDA Promoting Adaptive Clinical Trial Design With New Guidances
July 10, 2006
The FDA is actively seeking to encourage adaptive clinical trials by planning to issue five new guidances and setting up special teams to provide designers of adaptive clinical trials with consulting advice, a high-ranking FDA official announced.